Fysiofresh ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  17.9% 19.0% 6.7% 9.1% 20.4%  
Credit score (0-100)  9 7 34 26 4  
Credit rating  B B BBB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -6.2 26.7 675 449 271  
EBITDA  -6.2 26.7 603 406 -18.3  
EBIT  -6.2 26.7 603 406 -18.3  
Pre-tax profit (PTP)  -6.2 26.7 604.5 404.8 -18.3  
Net earnings  -4.1 20.8 471.5 315.6 -16.4  
Pre-tax profit without non-rec. items  -6.2 26.7 605 405 -18.3  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  40.5 61.3 533 373 105  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.7  
Balance sheet total (assets)  45.5 75.0 811 463 133  

Net Debt  -43.4 -73.6 -174 -84.8 -95.8  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -6.2 26.7 675 449 271  
Gross profit growth  -15.1% 0.0% 2,427.0% -33.4% -39.6%  
Employees  1 1 0 1 1  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  45 75 811 463 133  
Balance sheet change%  1.9% 65.0% 981.6% -43.0% -71.3%  
Added value  -6.2 26.7 603.3 405.8 -18.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 89.4% 90.3% -6.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -13.7% 44.3% 136.6% 63.7% -6.1%  
ROI %  -14.5% 52.5% 203.8% 89.6% -7.6%  
ROE %  -9.7% 40.9% 158.7% 69.7% -6.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  89.0% 81.7% 65.7% 80.7% 78.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  701.9% -275.7% -28.9% -20.9% 523.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  9.1 5.5 2.9 5.2 4.7  
Current Ratio  9.1 5.5 2.9 5.2 4.7  
Cash and cash equivalent  43.4 73.6 174.1 84.8 96.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  40.5 61.3 532.8 373.5 105.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -6 27 0 406 -18  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -6 27 0 406 -18  
EBIT / employee  -6 27 0 406 -18  
Net earnings / employee  -4 21 0 316 -16